Viewing Study NCT01682720


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-03-02 @ 7:01 PM
Study NCT ID: NCT01682720
Status: COMPLETED
Last Update Posted: 2014-10-09
First Post: 2012-09-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection
Sponsor: Gilead Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-09
Start Date Type: None
Primary Completion Date: 2013-10
Primary Completion Date Type: ACTUAL
Completion Date: 2014-01
Completion Date Type: ACTUAL
First Submit Date: 2012-09-05
First Submit QC Date: None
Study First Post Date: 2012-09-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-10-02
Results First Submit QC Date: None
Results First Post Date: 2014-10-09
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-10-08
Last Update Post Date: 2014-10-09
Last Update Post Date Type: ESTIMATED